pentetic acid has been researched along with Cell Transformation, Neoplastic in 14 studies
Pentetic Acid: An iron chelating agent with properties like EDETIC ACID. DTPA has also been used as a chelator for other metals, such as plutonium.
Cell Transformation, Neoplastic: Cell changes manifested by escape from control mechanisms, increased growth potential, alterations in the cell surface, karyotypic abnormalities, morphological and biochemical deviations from the norm, and other attributes conferring the ability to invade, metastasize, and kill.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Pretargeting prostate cancer with Bom-bsCx or Bom-bsFCx enabled fast delivery of high specific radioactivity ¹¹¹In- or ⁹⁹mTc-labeled polymer-drug conjugates resulting in visualization of lesions smaller than 1- 2 mm in diameter within 3 h." | 1.38 | Imaging small human prostate cancer xenografts after pretargeting with bispecific bombesin-antibody complexes and targeting with high specific radioactivity labeled polymer-drug conjugates. ( Ferris, C; Gada, K; Khaw, BA; Majewski, S; Panwar, R; Patil, V; Tekabe, Y; Varvarigou, A; Weisenberger, A, 2012) |
| "MDA-MB-468 and MDA-MB-231/H2N (231-H2N) breast cancer cells were incubated with (111)In-DTPA-anti-γH2AX-Tat (3MBq, 6MBq/μg) or a control radioimmunoconjugate, (111)In-DTPA-mIgG-Tat, and exposed to IR or bleomycin." | 1.38 | Amplification of DNA damage by a γH2AX-targeted radiopharmaceutical. ( Allen, D; Barbeau, J; Cornelissen, B; Darbar, S; Falzone, N; Kersemans, V; Smart, S; Vallis, KA, 2012) |
| "Tumors were clearly visualized 1 day after injecting 3." | 1.36 | PET imaging of HER1-expressing xenografts in mice with 86Y-CHX-A''-DTPA-cetuximab. ( Baidoo, KE; Brechbiel, MW; Garmestani, K; Milenic, DE; Nayak, TK; Regino, CA; Szajek, LP; Wong, KJ, 2010) |
| "In mice bearing LS-174T, PC-3, or A431 tumors, the tumor uptake at 3 d was 34." | 1.36 | Preparation, biological evaluation, and pharmacokinetics of the human anti-HER1 monoclonal antibody panitumumab labeled with 86Y for quantitative PET of carcinoma. ( Baidoo, KE; Brechbiel, MW; Garmestani, K; Milenic, DE; Nayak, TK, 2010) |
| "The MR features of pineal cysts, the difficulty of distinguishing benign cysts from cystic neoplasms, and the implications for surgical management are discussed." | 1.29 | A choroid plexus papilloma arising from an incidental pineal cyst. ( McClarty, BM; McGinn, GJ; Steven, DA, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (7.14) | 18.2507 |
| 2000's | 2 (14.29) | 29.6817 |
| 2010's | 11 (78.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bhattacharyya, S | 1 |
| Kurdziel, K | 1 |
| Wei, L | 1 |
| Riffle, L | 1 |
| Kaur, G | 1 |
| Hill, GC | 1 |
| Jacobs, PM | 1 |
| Tatum, JL | 1 |
| Doroshow, JH | 1 |
| Kalen, JD | 1 |
| Vilhelmsson-Timmermand, O | 1 |
| Santos, E | 1 |
| Thorek, DL | 1 |
| Evans-Axelsson, S | 1 |
| Bjartell, A | 1 |
| Lilja, H | 1 |
| Larson, SM | 1 |
| Strand, SE | 1 |
| Tran, TA | 1 |
| Ulmert, D | 1 |
| Burvenich, IJ | 1 |
| Parakh, S | 1 |
| Gan, HK | 2 |
| Lee, FT | 2 |
| Guo, N | 1 |
| Rigopoulos, A | 2 |
| Lee, ST | 1 |
| Gong, S | 1 |
| O'Keefe, GJ | 2 |
| Tochon-Danguy, H | 1 |
| Kotsuma, M | 1 |
| Hasegawa, J | 1 |
| Senaldi, G | 1 |
| Scott, AM | 2 |
| Price, EW | 1 |
| Edwards, KJ | 1 |
| Carnazza, KE | 1 |
| Carlin, SD | 1 |
| Zeglis, BM | 1 |
| Adam, MJ | 1 |
| Orvig, C | 1 |
| Lewis, JS | 1 |
| Bergstrom, D | 1 |
| Leyton, JV | 1 |
| Zereshkian, A | 1 |
| Chan, C | 1 |
| Cai, Z | 1 |
| Reilly, RM | 2 |
| Cornelissen, B | 2 |
| Kersemans, V | 2 |
| McLarty, K | 1 |
| Tran, L | 1 |
| Vallis, KA | 2 |
| Nayak, TK | 2 |
| Regino, CA | 1 |
| Wong, KJ | 1 |
| Milenic, DE | 2 |
| Garmestani, K | 2 |
| Baidoo, KE | 2 |
| Szajek, LP | 1 |
| Brechbiel, MW | 2 |
| Mountain, AJ | 1 |
| Jones, GR | 1 |
| Saunder, TH | 1 |
| Sagona, J | 1 |
| Smyth, FE | 1 |
| Johns, TG | 1 |
| Govindan, SV | 1 |
| Goldenberg, DM | 1 |
| Old, LJ | 1 |
| Sankavaram, K | 1 |
| Freake, HC | 1 |
| Patil, V | 1 |
| Gada, K | 1 |
| Panwar, R | 1 |
| Varvarigou, A | 1 |
| Majewski, S | 1 |
| Weisenberger, A | 1 |
| Ferris, C | 1 |
| Tekabe, Y | 1 |
| Khaw, BA | 1 |
| Darbar, S | 1 |
| Allen, D | 1 |
| Falzone, N | 1 |
| Barbeau, J | 1 |
| Smart, S | 1 |
| Steven, DA | 1 |
| McGinn, GJ | 1 |
| McClarty, BM | 1 |
| Chen, XG | 1 |
| Li, Y | 1 |
| Yan, CH | 1 |
| Li, LN | 1 |
| Han, R | 1 |
14 other studies available for pentetic acid and Cell Transformation, Neoplastic
| Article | Year |
|---|---|
Zirconium-89 labeled panitumumab: a potential immuno-PET probe for HER1-expressing carcinomas.
Topics: Animals; Antibodies, Monoclonal; Breast Neoplasms; Cell Line, Tumor; Cell Transformation, Neoplastic | 2013 |
Radiolabeled antibodies in prostate cancer: a case study showing the effect of host immunity on antibody bio-distribution.
Topics: Animals; Cell Line, Tumor; Cell Transformation, Neoplastic; Humans; Immunocompetence; Immunoconjugat | 2015 |
Molecular Imaging and Quantitation of EphA2 Expression in Xenograft Models with 89Zr-DS-8895a.
Topics: Animals; Antibodies, Monoclonal, Humanized; Cell Line, Tumor; Cell Transformation, Neoplastic; Defer | 2016 |
A comparative evaluation of the chelators H4octapa and CHX-A″-DTPA with the therapeutic radiometal (90)Y.
Topics: Animals; Cell Line, Tumor; Cell Transformation, Neoplastic; Chelating Agents; Ethylamines; Female; I | 2016 |
Paradoxical effects of Auger electron-emitting (111)In-DTPA-NLS-CSL360 radioimmunoconjugates on hCD45(+) cells in the bone marrow and spleen of leukemia-engrafted NOD/SCID or NRG mice.
Topics: Amino Acid Sequence; Animals; Bone Marrow; Cell Line, Tumor; Cell Transformation, Neoplastic; Electr | 2016 |
In vivo monitoring of intranuclear p27(kip1) protein expression in breast cancer cells during trastuzumab (Herceptin) therapy.
Topics: Amino Acid Sequence; Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Breast Neop | 2009 |
PET imaging of HER1-expressing xenografts in mice with 86Y-CHX-A''-DTPA-cetuximab.
Topics: Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Cell Line, Tumor; Cell Transform | 2010 |
Preparation, biological evaluation, and pharmacokinetics of the human anti-HER1 monoclonal antibody panitumumab labeled with 86Y for quantitative PET of carcinoma.
Topics: Animals; Antibodies, Monoclonal; Area Under Curve; Biological Transport; Cell Line, Tumor; Cell Tran | 2010 |
Immuno-PET quantitation of de2-7 epidermal growth factor receptor expression in glioma using 124I-IMP-R4-labeled antibody ch806.
Topics: Amino Acid Sequence; Animals; Antibodies, Monoclonal; Cell Line, Tumor; Cell Transformation, Neoplas | 2010 |
The effects of transformation and ZnT-1 silencing on zinc homeostasis in cultured cells.
Topics: Animals; Biological Transport; Carcinoma, Hepatocellular; Cation Transport Proteins; Cell Division; | 2012 |
Imaging small human prostate cancer xenografts after pretargeting with bispecific bombesin-antibody complexes and targeting with high specific radioactivity labeled polymer-drug conjugates.
Topics: Animals; Antibodies, Bispecific; Antibodies, Monoclonal; Antineoplastic Agents; Bombesin; Cell Line, | 2012 |
Amplification of DNA damage by a γH2AX-targeted radiopharmaceutical.
Topics: Animals; Bleomycin; Breast Neoplasms; Cell Line, Tumor; Cell Transformation, Neoplastic; DNA Breaks, | 2012 |
A choroid plexus papilloma arising from an incidental pineal cyst.
Topics: Adult; Brain Diseases; Cell Transformation, Neoplastic; Choroid Plexus Neoplasms; Contrast Media; Cy | 1996 |
Cancer chemopreventive activities of S-3-1, a synthetic derivative of danshinone.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Anticarcinogenic Agents; Benzo(a)pyrene; Benzofurans; Bep | 2001 |